Cognition Therapeutics Inc
CGTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001455365
No open-market purchases or sales by Cognition Therapeutics Inc insiders were filed in the last 90 days; 66 institutions reported holding it in 13F filings for Q2 2026, worth $26.0M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Cognition Therapeutics Inc as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- +3 vs. Q1 2023
- Shares held
- 7.10M
- −39.3K (−0.5%) vs. Q1 2023
- Total value
- $13.0M
- −$1.15M (−8.1%) vs. Q1 2023
- New holders
- 6
- 9 more added
- Sold out
- 3
- 8 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CGTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 66 | $26.0M |
| Q1 2026 | 75 | $16.3M |
| Q4 2025 | 78 | $28.9M |
| Q3 2025 | 68 | $28.7M |
| Q2 2025 | 48 | $3.50M |
| Q1 2025 | 51 | $4.89M |
| Q4 2024 | 45 | $7.78M |
| Q3 2024 | 40 | $1.99M |
| Q2 2024 | 46 | $8.82M |
| Q1 2024 | 47 | $12.9M |
| Q4 2023 | 37 | $13.2M |
| Q3 2023 | 36 | $10.4M |
| Q2 2023 | 35 | $13.0M |
| Q1 2023 | 32 | $14.1M |
| Q4 2022 | 34 | $10.1M |
| Q3 2022 | 31 | $9.67M |
| Q2 2022 | 28 | $11.4M |
| Q1 2022 | 27 | $4.58M |
| Q4 2021 | 20 | $8.44M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Cognition Therapeutics Inc; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Pathstone Family Office, LLC | 2,205,377 | $4.04M | 0.06% | −5,000−0.2% | Reduced |
| AIGH Capital Management LLC | 2,038,853 | $3.73M | 1.52% | +1,0000.0% | Added |
| Vanguard Group Inc | 668,425 | $1.22M | 0.00% | +25,035+3.9% | Added |
| Worth Venture Partners, LLC | 508,719 | $931.0K | 0.51% | +7,000+1.4% | Added |
| Carlson Capital L P | 245,000 | $448.4K | 0.04% | −169−0.1% | Reduced |
| Perigon Wealth Management, LLC | 223,500 | $409.0K | 0.02% | −1,500−0.7% | Reduced |
| American Financial Group Inc | 205,000 | $375.0K | 0.12% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 176,498 | $323.0K | 0.00% | +53,900+44.0% | Added |
| Kestra Advisory Services, LLC | 173,784 | $318.0K | 0.00% | +78,784+82.9% | Added |
| Commonwealth Equity Services, LLC | 93,235 | $171.0K | 0.00% | −75,457−44.7% | Reduced |
| Bridgeway Capital Management, LLC | 66,200 | $121.1K | 0.00% | 00.0% | Unchanged |
| Voss Capital, LLC | 60,222 | $110.2K | 0.01% | −99,751−62.4% | Reduced |
| BlackRock Inc. | 58,417 | $106.9K | 0.00% | +20,678+54.8% | Added |
| Fca Corp | 51,471 | $94.2K | 0.03% | 00.0% | Unchanged |
| Castle Wealth Management LLC | 43,380 | $79.4K | 0.06% | 00.0% | Unchanged |
| Neumann Capital Management, LLC | 33,382 | $61.1K | 0.03% | 00.0% | Unchanged |
| Northern Trust Corp | 30,722 | $56.2K | 0.00% | +1,538+5.3% | Added |
| State Street Corp | 30,250 | $55.4K | 0.00% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 26,561 | $48.0K | 0.00% | −2,000−7.0% | Reduced |
| Northeast Financial Consultants Inc | 24,500 | $44.8K | 0.00% | 00.0% | Unchanged |
| Bangor Savings Bank | 24,019 | $44.0K | 0.00% | +5,000+26.3% | Added |
| Baird Financial Group, Inc. | 22,393 | $41.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 21,869 | $40.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 17,795 | $32.6K | 0.00% | +17,795 | New |
| Mercer Global Advisors Inc | 15,951 | $29.0K | 0.00% | +15,951 | New |
| Charles Schwab Investment Management Inc | 11,965 | $21.9K | 0.00% | +11,965 | New |
| Rock Creek Group, LP | 10,222 | $18.7K | 0.00% | −39,778−79.6% | Reduced |
| Northwestern Mutual Wealth Management Co | 5,867 | $10.7K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 4,262 | $7.80K | 0.00% | −1,063−20.0% | Reduced |
| Bray Capital Advisors | 2,250 | $4.12K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 610 | $1.12K | 0.00% | +610 | New |
| Wells Fargo & Company | 137 | $251 | 0.00% | +13+10.5% | Added |
| JPMorgan Chase & Co | 50 | $92 | 0.00% | +50 | New |
| FMR LLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 254 | $0 | 0.00% | +254 | New |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −28,236−100.0% | Sold out |
| Neuberger Berman Group LLC | 0 | $0 | 0.00% | −15,884−100.0% | Sold out |
| Diligent Investors, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |